GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

Affordable semaglutide syringes starting at Rs 350 could improve access to diabetes and obesity treatment while supporting ...

Long-awaited glucagon-like peptide-1 agonist (GLP-1) tablets don’t appear to be stealing significant market share from GLP-1 injectables. Rather, industry experts told MD+DI that they expect ...

Users of GLP-1 weight loss drugs now have a choice: injections or pills. There are multiple drug choices within each category, but both methods of administration provide significant weight loss ...

The launch comes as India grapples with rising diabetes and obesity cases, offering patients another treatment option designed to improve long-term adherence.

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

The GLP-1 medicine Wegovy is available as a shot or a pill. Which one is better for you? Compare them here. You’ve likely heard buzz (and seen commercials) about GLP-1 drugs for weight management, ...

Three out of four new biologic approvals are now device-based pens, prefilled syringes, autoinjectors, and increasingly ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

Novo Nordisk's new Wegovy GLP-1 pill appears to be expanding the obesity treatment market, drawing in new patients rather than converting existing ones from injections. CNBC spoke with five U.S.

On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...